ArticleCanada communicable disease report = Releve des maladies transmissibles au Canada2010
STATEMENT ON THE RECOMMENDED USE OF HERPES ZOSTER VACCINE: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI)*
Article in Canada communicable disease report = Releve des maladies transmissibles au Canada, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 3 syntheses or guidelines pooled it.
- Systematic review and meta-analysis of recombinant herpes zoster vaccine in immunocompromised populations.PloS one · 2024Pooled it
- Systematic review of models assessing the economic value of routine varicella and herpes zoster vaccination in high-income countries.BMC public health · 2015Pooled it
- Update on herpes zoster vaccination: a family practitioner's guide.Canadian family physician Medecin de famille canadien · 2011Guideline
- Safety, immunogenicity, and lot-to-lot consistency of live attenuated varicella vaccine in 1-3 years old children: a double-blind, randomized phase III trial.Human vaccines & immunotherapeutics · 2019Trial
- Updated Public Health Impact and Cost Effectiveness of Recombinant Zoster Vaccine in Canadian Adults Aged 50 Years and Older.PharmacoEconomics - open · 2024Article
- Summary of the NACI Update on Herpes Zoster Vaccines.Canada communicable disease report = Releve des maladies transmissibles au Canada · 2018Article
- Evaluation of the effect of chickenpox vaccination on shingles epidemiology using agent-based modeling.PeerJ · 2018Article
- Increasing incidence associated with herpes zoster infection in British Columbia, Canada.BMC infectious diseases · 2016Article
- Immunization in Canada: Update for 2015.The Journal of the Canadian Chiropractic Association · 2016Article
- Herpes zoster vaccine (HZV): utilization and coverage 2009 - 2013, Alberta, Canada.BMC public health · 2014Article
- Zoster vaccine.Canadian family physician Medecin de famille canadien · 2013Article
- Annual adult health checkup: update on the Preventive Care Checklist Form(©).Canadian family physician Medecin de famille canadien · 2012Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.